Cargando…
Cardiac implantable electronic device surgery with interruption of warfarin forgoing post-operative bridging therapy in patients with moderate or high thromboembolic risks
BACKGROUND: For patients taking warfarin and undergoing pacemaker or implantable cardioverter-defibrillator surgery, clinical evidence and guidelines support continuation of warfarin therapy, as opposed to interruption of warfarin therapy with heparin bridging. Interruption of warfarin without post-...
Autores principales: | Ng, Andrew Kei-Yan, Ng, Pauline Yeung, Tam, Eva Wai-Ying, Siu, Chung-Wah, Fan, Katherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082611/ https://www.ncbi.nlm.nih.gov/pubmed/33926467 http://dx.doi.org/10.1186/s12959-021-00279-6 |
Ejemplares similares
-
High-Intensity Statin vs. Low-Density Lipoprotein Cholesterol Target for Patients Undergoing Percutaneous Coronary Intervention: Insights From a Territory-Wide Cohort Study in Hong Kong
por: Ng, Andrew Kei-Yan, et al.
Publicado: (2021) -
Forgoing earned incentives to signal pure motives
por: Kirgios, Erika L., et al.
Publicado: (2020) -
Falling behind: The role of student loans on forgoing healthcare
por: Babula, Michael, et al.
Publicado: (2021) -
Association Between Radial Versus Femoral Access for Percutaneous Coronary Intervention and Long‐Term Mortality
por: Ng, Andrew Kei‐Yan, et al.
Publicado: (2021) -
Association between proton pump inhibitors after percutaneous coronary intervention and risk of gastric cancer
por: Ng, Andrew Kei-Yan, et al.
Publicado: (2021)